SEC Form 4 · accession 0001022079-17-000150
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catherine T. Doherty
Officer — SVP, Group Exec. Clin. Fran.
Period of report
Jun 19, 2017
Accepted (ET)
Jun 21, 2017 · 4:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 19, 2017 | M | 9,167 | $57.35 | A | 78,582 | D | |
| Common Stock | Jun 19, 2017 | M | 44,000 | $57.605 | A | 122,582 | D | |
| Common Stock | Jun 19, 2017 | M | 6,595 | $56.12 | A | 129,177 | D | |
| Common StockF2 | Jun 19, 2017 | S | 8,852 | $107.542 | D | 120,325 | D | |
| Common StockF3 | Jun 19, 2017 | S | 315 | $108.156 | D | 120,010 | D | |
| Common StockF4 | Jun 19, 2017 | S | 42,636 | $107.52 | D | 77,374 | D | |
| Common StockF5 | Jun 19, 2017 | S | 1,364 | $108.141 | D | 76,010 | D | |
| Common StockF4 | Jun 19, 2017 | S | 6,418 | $107.544 | D | 69,592 | D | |
| Common Stock | Jun 19, 2017 | S | 177 | $108.15 | D | 69,415 | D | |
| Common StockF6 | holding | — | — | — | 3,780 | I | 401(k)/SDCP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F7 | $57.35 | Jun 19, 2017 | M | 9,167 | D | — | May 16, 2021 | Common Stock | 9,167 | 0 | D |
| Stock Options (Right to Buy)F8 | $57.605 | Jun 19, 2017 | M | 44,000 | D | — | Feb 27, 2022 | Common Stock | 44,000 | 0 | D |
| Stock Options (Right to Buy)F9 | $56.12 | Jun 19, 2017 | M | 6,595 | D | — | Feb 25, 2023 | Common Stock | 6,595 | 0 | D |
Explanation of responses
- F1This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 18, 2017.
- F2This transaction was executed in multiple trades at prices ranging from $107.14 to $108.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $108.15 to $108.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $107.12 to $108.11. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $108.12 to $108.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- F7The options vested in three annual installments beginning with the first on May 16, 2012, the second on May 16, 2013 and the final on May 16, 2014.
- F8The options vested in three annual installments beginning with the first on February 27, 2013, the second on February 27, 2014 and the final on February 27, 2015.
- F9The options vested in three annual installments beginning with the first on February 25, 2014, the second on February 25, 2015 and the final on February 25, 2016.